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The insulin signaling pathway has been implicated in several physiological and developmental processes. In mammals, it
controls expression of 3-Hydroxy-3-Methylglutaryl CoA Reductase (HMGCR), a key enzyme in cholesterol biosynthesis. In
insects, which can not synthesize cholesterol de novo, the HMGCR is implicated in the biosynthesis of juvenile hormone (JH).
However, the link between the insulin pathway and JH has not been established. In Drosophila, mutations in the insulin
receptor (InR) decrease the rate of JH synthesis. It is also known that both the insulin pathway and JH play a role in the control
of sexual dimorphism in locomotor activity. In studies here, to demonstrate that the insulin pathway and HMGCR are
functionally linked in Drosophila, we first show that hmgcr mutation also disrupts the sexual dimorphism. Similarly to the InR,
HMGCR is expressed in the corpus allatum (ca), which is the gland where JH biosynthesis occurs. Two p[hmgcr-GAL4] lines were
therefore generated where RNAi was targeted specifically against the HMGCR or the InR in the ca. We found that RNAi-HMGCR
blocked HMGCR expression, while the RNAi-InR blocked both InR and HMGCR expression. Each RNAi caused disruption of
sexual dimorphism and produced dwarf flies at specific rearing temperatures. These results provide evidence: (i) that HMGCR
expression is controlled by the InR and (ii) that InR and HMGCR specifically in the ca, are involved in the control of body size
and sexual dimorphism of locomotor activity.
Citation: Belgacem YH, Martin J-R (2007) Hmgcr in the Corpus Allatum Controls Sexual Dimorphism of Locomotor Activity and Body Size via the
Insulin Pathway in Drosophila. PLoS ONE 2(1): e187. doi:10.1371/journal.pone.0000187
INTRODUCTION
The high degree of similarity displayed among species by the
insulin signaling pathway highlights its importance in develop-
mental and physiological processes. In mammals, insulin receptor
(InR) and insulin like growth factor receptor (IGFR) share the
same signaling pathway components and insulin receptor sub-
strates (IRS), which mediate functions, such as growth [1,2],
fertility and glucose homeostasis [3]. They also modulate several
metabolic pathways, such as cholesterol biosynthesis [3,4] or lipid
metabolism [5]. In lower organisms like Drosophila, seven genes
coding for insulin like ligands have been described [6]. Four of
them are synthesized in neurons of the Pars Intercerebralis (PI) called
Insulin Producing Cells (IPCs) [6–9]. In contrast, only one insulin
like receptor (InR) has been described [10] with a conserved
structure. Functionally, in comparison to mammals, its action is
similar, during development, to insulin like growth factor receptor
(IGFR) [8,11–18], while in adult stage, to the endocrine function
of the InR [19–21]. Indeed, mutations affecting InR or chico, the
IRS homologue, or ablation of insulin producing cells (IPCs),
cause growth retardation [12,15,16], reduce body and organ size
[6,8,16,22], increase sugar level [8,13–15,21], and longevity
[15,16,23]. These phenotypes resemble those obtained for IRS-1
[24] or IRS-2 knockout mice [25].
The highly conserved insulin pathway between Drosophila and
mammals, and the wide variety of genetic and molecular tools of
Drosophila, gives us the opportunity to use this relatively simple
model to identify new roles of the insulin pathway. Indeed, recent
studies demonstrated that the insulin pathway is an integrative
system adapting growth to food availability [7,26,27]. Addition-
ally, Wu and collaborators implicated InR in food intake and
noxious food aversion [19,20]. In a previous study, we also
reported a new role for insulin pathway in Drosophila, by showing
its implication in the control of a sexual dimorphism in locomotor
activity [21]. This sexually dimorphic behavior comprises
differences in the temporal pattern of locomotor activity,
represented by a different number of activity/inactivity periods
(or start/stop number) between males and females when flies are
freely walking during a determined period (5 hours) [21,28–30].
A disruption in the insulin pathway either in IPCs or at the InR
level abolishes sexual dimorphism [21]. In an earlier study, we
found that the Juvenile Hormone (JH), one of the main hormones
in insects, is involved in the control of start/stop number [28]. JH
is synthesized in the ca [31], while the 3-Hydroxy-3-Methylglutaryl
Co Enzyme A Reductase (HMGCR) [31] is the key step in JH
biosynthesis. Additionally, ectopic application of Fluvastatin, an
HMGCR inhibitor, abolishes sexual dimorphism [28]. Interest-
ingly, we previously found that InR is expressed in the ca [21],
while Tatar and collaborators demonstrated that a mutation
affecting the InR leads to a decrease in the JH level [15].
Together, these data suggest that there is a functional link between
the insulin pathway and JH synthesis and/or release in the ca.W e
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the insulin pathway and JH in the ca.
In mammals, HMGCR is a transmembrane glycoprotein
anchored in the smooth endoplasmic reticulum [32] and is
principally found in liver tissues [33]. It catalyzes the production of
mevalonate, which represents the rate limiting step of cholesterol
biosynthesis in the liver [34]. Tight control on cholesterol produc-
tion is critical in physiology, since defects reducing cholesterol
synthesis leads to the Smith-Lemli-Opizt syndrome [35]. Alterna-
tively, over production causes a predisposition to atherosclerotic
vascular diseases [36]. HMGCR has also been implicated in other
processes like embryogenesis [37] and cancer [38,39]. The reduc-
tase is continuously transcribed and is regulated by a number of
factors, including negative feed back from cholesterol [40], or
remarkably by insulin that strongly stimulates HMGCR synthesis
[40–42]. Regulation involves a family of helix-loop-helix tran-
scription factors, called sterol response element binding protein
(SREBP) and particularly SREBP-1c [42,43].
In insects, cholesterol is not synthesized de novo [44]. However,
in the ca, HMGCR catalyzes the synthesis of mevalonate, the
precursor of the JH family components [31]. In Drosophila, hmgcr
gene (also named columbus (clb)), has been cloned and is implicated
in germ cell guidance during development [45], as well as further
in zebrafish [46]. HMGCR also plays a role in the potentiation of
hedgehog signaling [47] as well as in neurodegenerative disease
[48]. However, little is known about its regulation. Although
a homologue of SREBP has been identified in Drosophila (HLH106)
and is expressed in the ca [49,50], there is still no clearly
established link between HMGCR and this transcription factor.
Here, we show that a mutation affecting the hmgcr gene in
Drosophila, abolishes sexual dimorphism in locomotor activity. We
also show that this phenotype can be rescued by over expression of
hmgcr specifically in the ca. For the latter studies, we generated two
independent p[hmgcr-GAL4] lines to specifically drive either
a RNAi-HMGCR or an RNAi-InR in the ca. In both cases, we
show that locomotor behavior mimics the hmgcr mutant (lack of the
sexual dimorphism), highlighting the role of the hmgcr and the
insulin pathway in the ca. Furthermore, we also show that silencing
inr gene within the ca results in a reduction of HMGCR, suggesting
a transcriptional control exerted by insulin signaling pathway on
the HMGCR in the ca. Finally, targeting either RNAi-InR or
RNAi-HMGCR specifically in the ca, yields dwarf flies, suggesting
a very specific action of InR and HMGCR within the ca, in the
control of development.
RESULTS
Sexual dimorphism in locomotor activity is
abolished in the hmgcr mutant
The number of activity/inactivity phases, equivalent to the start/
stop number, has been shown to be different between males and
females in normal wild-type (Canton Special (CS)) flies [30].
Application of Fluvastatin, an HMGCR inhibitor [51] abolishes
the sexual dimorphism [28]. In an attempt to determine whether
HMGCR is directly involved in the control of this dimorphism, we
quantified the locomotor activity of flies carrying a homozygous
mutation affecting the gene hmgcr. Since all known hmgcr mutations
were homozygous lethal [45], and heterozygous combinations
[(P{PZ}hmgcr
01152/CS) and (hmgcr
C14.5/CS)] exhibit a wild-type
like phenotype (data not shown), we used an hypomorphic
mutation of the hmgcr gene, a line carrying a P element in the 39
region of this gene (P{PZ}l(3)04684
04684), also known as 11635
line (Bloomington Stock Center number). When reared at 24uC,
the 11635 homozygous flies are also lethal. However, when reared
at 19uC, 5 and 10% of males and females, respectively, which are
developmentally delayed, attempt to survive until adulthood.
Quantification of the locomotor activity of these flies indicates that
the start/stop number for both sexes is the same (Figure 1a).
However, at this stage of the study, we could not exclude that the P
element affects other genes in the 39 region of hmgcr. To confirm
that the effects observed in the 11635 homozygous mutants are
due to a perturbation of the hmgcr gene, we genetically rescued the
phenotype by directing the expression of the the hmgcr gene in the
11635 homozygous mutant. In these studies, we used the yeast
derived UAS/GAL4 system to specifically target the hmgcr cDNA:
p[UAS-hmgcr] (also known and referred here as: UAS-clb) [45] with
different p[GAL4] driver lines in an homozygous 11635 genetic
background mutant. The pan-neural p[elav-GAL4] (elav-GAL4)
[52] or the head specific fat body p[takeout-GAL4] (to-GAL4) [53]
drivers were not able to rescue lethality. However, the p[actin-
Figure 1. The sexual dimorphism in locomotor activity is disrupted in
hmgcr mutant. a) Flies homozygous for a P element inserted in the 39
region of the hmgcr gene (hmgcr
11635/hmgcr
11635) do not exhibit
a sexually dimorphic start/stop number. Flies heterozygous for this P
element insertion (hmgcr
11635/CS) behave like wild-type controls
Canton-S flies. For all graphics representing the start/stop number in
this study, blue and red are males and females respectively, while the
number in the boxes indicates the number of flies recorded for each
genotype. CS=Canton-S. Mean6SEM is represented and all statistical
tests are done using an Anova-Manova test (Statistica software). *
p,0.05; ** p,0.01; *** p,0.001. b) Targeted expression of p[UAS-clb]
under the control the p[da-GAL4] driver in flies homozygous for the
hmgcr
11635 allele (p[da-GAL4]; hmgcr
11635/UAS-clb, hmgcr
11635) is suffi-
cient to rescue both the lethality and the sexual dimorphism, observed
in hmgcr
11635/hmgcr
11635 flies. However, the p[act-GAL4] driver (p[act-
GAL4]; hmgcr
11635/UAS-clb, hmgcr
11635) rescue the lethality, but not the
sexual dimorphism.
doi:10.1371/journal.pone.0000187.g001
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tissues and cells (but not considered an ubiquitous driver),
completely rescues lethality but, surprisingly, does not rescue the
sexual dimorphism (Figure 1b). Finally, the p[daughterless-GAL4]
(da-GAL4), an ubiquitous driver [55] was sufficient to rescue both
lethality [partly in males (75%) and completely in females
(Figure 1b)] and the start/stop number. The rescue of the
locomotor activity defect in the P element 11635 mutant flies
(hmgcr
11635 allele) confirms that this phenotype resulted from
mutation to the hmgcr gene by the P element insertion. However,
to elucidate the difference in the rescue (lethality and sexual
dimorphism) obtained with those two drivers, act-GAL4 versus da-
GAL4, we also looked precisely at their respective expression
patterns, using the reporter transgene UAS-gfp (green fluorescent
protein). These studies showed that GFP was found to be expressed
in the ca under the sole control of the da-GAL4 line, but not in the
act-GAL4 (data not shown), suggesting a specific role for HMGCR
in the ca to control sexual dimorphism. These results suggest firstly,
that the HMGCR is involved in the control of sexual dimorphism
and secondly, that its action may be required in the ca.
hmgcr is expressed in the fat body and the corpus
allatum in adult flies
To determine the expression pattern of hmgcr, we performed
immunostaining. In mammals, the enzyme has been found in
a wide variety of tissues including brain, testis and liver [40].
Polyclonal antibodies raised against the human HMGCR [33]
were used to determine the expression pattern of HMGCR in
Drosophila tissues. First, we showed that the reductase is expressed
in residual larval fat body (Figure 2a), which corresponds to
residual adipocytes inheritated from larval stages that disappear in
flies within approximately three days after hatching. HMGCR is
also detected in some cells at the periphery of the brain (Figure 2b
and 2c). The presence of this enzyme in the brain has already been
indirectly suggested by Tscha ¨pe and collaborators [48]. These
authors have shown that HMGCR could play a role in neuronal
tissues. Indeed, the ectopic expression of the reductase, under the
control of the pan-neural driver, elav-GAL4, in flies carrying
a mutation leading to neurodegenerescence, is sufficient to rescue
the lethal phenotype. In Figure 2c, we can see an immunoreactive
cluster of cells located in the pars intercerebralis (PI). Outside the
head, the reductase is also found to be expressed in the digestive
tract, especially in the cardia (Figure 2d). Finally, the HMGCR is
also expressed in the ca (Figure 2e), in accordance with previous
results suggesting a role for the reductase in this tiny gland.
Identification of hmgcr regulatory sequences and
genesis of two p[hmgcr-GAL4] lines
To date, no specific GAL4-driver line has been reported to be
specifically expressed in the ca in adult fly. Since we found that
hmgcr is expressed in the ca, suggesting a specific role in this
structure, we generated two p[hmgcr-GAL4] lines, in which the
putative genomic DNA promoter sequence specifically drives the
GAL4 gene. The Drosophila hmgcr gene is composed of 8 exons, in
which 5 are coding exons. Two mRNA are transcribed according
to two different initiation sites (Figure 3a). RNAA (3,972 kb)
comprises the first, but not the second and third exons. The RNAB
(3,833 kb) starts only with the second exon. Both mRNA share the
other three encoding exons. In order to construct two p[GAL4]
lines corresponding respectively to the two putative mRNA
promoters, we first selected a sequence of 3,8 kb upstream to
the first exon initiation site, and secondly, a sequence of 10,8 kb
upstream to the second exon. Each sequence was cloned and fused
upstream to the coding sequence of the yeast GAL4 transcription
factor gene. In these two sequences, based on the already identi-
fied mammalian sequence, specific cis-acting transcription factor
recognition sites were identified (Figure 3a), especially E-boxes and
SRE (Sterol Responding Elements) that are known to be the
targets of SREBP (Sterol Responding Element Binding Protein).
The two cloned constructs were then used to generate two
independent and specific p[hmgcr-GAL4] transgenic lines called
DI-3 and DI-11, corresponding respectively to the RNAA and
RNAB promoters. In an initial step, we determined if the two lines
were functional. Using the UAS-gfp as reporter, we determined
their expression pattern. Two days old DI-3/UAS-gfp flies were
found to express the reporter gene gfp in the residual larval fat
body (data not shown). GFP was also detected in some PI cells
(data not shown) but not in other brain neurons. Moreover,
a strong expression of the reporter gene was found in the ca
(Figure 3c). The ca is a very small gland located near the corpus
cardiacum (cc) and the cardia, a compartment of the digestive tract
(Figure 3b). To confirm that the observed signal corresponds to the
ca, a double immunostaining against GFP and the Adipokinetic
Hormone (AKH) [56] was performed (Figure 3d). AKH is known
to label specifically the cc [56,57], allowing the presence of GFP in
the ca. In a second step, double immunostaining against GFP and
HMGCR was performed (Figure 3e), allowing colocalization of
the two proteins in ca cells, to be shown. Thus, this expression
pattern confirms that the 3,8 kb length promoter cloned fragment
Figure 2. hmgcr is expressed in the brain, the larval fat body, the
cardia and the corpus allatum. Immunohistological staining showing
the HMGCR expression in various tissues, in adult fly. a, b, c) The HMGCR
is expressed in the fat body in flies younger than 4 days (a, left). In flies
older than 5 days, no HMGCR expression is detectable (a, right). The
HMGCR is also expressed in some neurons, principally in the cortex of
the brain (cx) (b) and some cells of the pars intercerebralis (PI) (c). oe:
eosophagus, eb: ellipsoid-body. d, e) In the body, the reductase is
detected in the cardia (d) and in the corpus allatum (ca) (e). For
a negative control of the HMGCR staining, see Figure 5b, in comparison
with figures 5a, c, d, e and g. Scale bar=25 mm.
doi:10.1371/journal.pone.0000187.g002
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body cells. However, the previously determined endogenous
HMGCR expression pattern does not fully overlap with the DI-
3 driver expression pattern. Notably, in DI-3/UAS-gfp flies older
than 4 days, a signal is detectable in a thin layer of the cardia, but is
no longer found in the ca (Figure 3f), whereas GFP expression is
still found in PI cells (data not shown). It is likely that the residual
fat body cells are not detected because of the lack of these cells in
5 day old flies. These results show that DI-3 presents a temporally
dynamic expression pattern. This also tends to suggest distinct
roles for HMGCR in some tissues of young and older adults. By
contrary to DI-3, DI-11 has a very stable temporal expression
pattern. The reporter gene UAS-gfp driven by DI-11 shows
a strong expression in the ca (Figure 3g). As for DI-3, a double
immunostaining reveals that GFP and HMGCR are colocalized in
the same cells of the ca (Figure 3h). In brief, DI-3 and DI-11 drive
reporter gene expression in a pattern strictly included within the
previously shown endogenous HMGCR expression pattern, as
revealed by the immunostaining. The DI-3 follows partially and
temporally the expression of the endogenous gene, while the DI-11
seems to follow permanently the expression in the ca. These two
lines are therefore valuable tools to specifically target any reporter
gene in the ca, so that studies on the putative role of HMGCR in
this specific tiny gland can be undertaken.
Targeted expression of hmgcr cDNA in the corpus
allatum rescues the hmgcr mutant phenotype
We made the hypothesis that the lack of the sexual dimorphism in
locomotor activity in the hmgcr
11635 mutant could be due specifi-
cally to the lack of the hmgcr in the ca. First, driving UAS-clb with
DI-3 in the homozygous mutant background (DI-3; UAS-clb,
hmgcr
11635/hmgcr
11635) was not sufficient to rescue lethality at 24uC.
As we previously observed that act-GAL4 driving UAS-clb was
sufficient to allow (hmgcr
11635/hmgcr
11635) flies to survive until
adulthood, but not to rescue the sexual dimorphism in locomotor
activity, we combined these two driver lines (act-GAL4 and DI-3)
in the same fly, to drive hmgcr gene expression. Interestingly, the
presence of the two drivers, act-GAL4 and DI-3, in the mutant
genetic background (hmgcr
11635/hmgcr
11635) was sufficient to rescue
the sexual dimorphism. Indeed, figure 4 shows that 2 days old
Figure 4. Targeted expression of the HMGCR in the corpus allatum
rescues the hmgcr mutant phenotype. p[DI-3-GAL4] plus p[act-GAL4]
in the same flies are sufficient to rescue the sexual dimorphism
disrupted in hmgcr
11635/hmgcr
11635 flies (DI-3, act-GAL4; hmgcr
11635/
UAS-clb; hmgcr
11635). This suggests a specific role for the HMGCR in the
ca to control the sexual dimorphism. Interestingly, this rescue occurs in
two days old flies, but not in the same flies of 5 days old.
doi:10.1371/journal.pone.0000187.g004
Figure 3. Genesis and expression pattern of the two transgenic
p[hmgcr-GAL4] lines. a) Promoters and genomic regions of hmgcr
gene. Two mRNAs are transcribed (mRNAA and mRNAB) under the
control of two distinct promoter regions. After splicing, the encoding
regions of the two cDNA are identical. A computer analysis of the
genomic DNA region has allowed to find two E-Box consensus
sequences (CATGTG) [63] localized at 23194 to 23188 and 21315 to
21309, and one E-Box High affinity (GATGACCCGGTCGAGGAG) [64]
localized at 22051 to 22033, comprised in a region of 3,8 kb just
upstream of the first exon of hmgcr. We then hypothesized that this
region could control the RNAA transcription, and cloned and used it to
generate the p[DI-3-GAL4] (DI-3) line. To generate the p[DI-11-GAL4]
(DI-11) line, we cloned a fragment of 10,6 kb of the first intron (+2733 to
+13525) in which we found an E-box consensus [63] (+2911 to +2916)
and one SRE1 (AATTAGTCTGTACCCCAATT) [64] (+3551 to +3570). We
hypothesized that this region could control the RNAB transcription. b)
Schematic lateral view of the head and thorax of Drosophila. card:
cardia; ca: corpus allatum; br: brain. c–h) The two p[DI-GAL4] lines (DI-3
and DI-11) drive the expression of GFP in the ca. c) At low magnification
(10X), the ca, in green, is detected by using primary antibodies against
GFP and secondary antibodies labeled with FITC (green) in flies DI-3/
GFP. The background is artificially colored in blue. d) The corpus
cardiacum (cc) is a structure located near the ca. To confirm that the
GFP is expressed in the ca, the corpus cardiacum (cc) was stained using
an anti-AKH antibody [56] directly conjugated to the rhodamine (red).
Thus, we can visualize the ca in green and the cc in red. e) The GFP (left,
green) and HMGCR (middle, red) are detected with primary and
secondary antibody. Those last are labeled respectively with FITC
(green) or Cy3 (red). When merged, we can see that the GFP and
HMGCR are colocalized (right panel: yellow), confirming that the DI-3
drives the GFP in the same cells of the ca that express the HMGCR. f)
Dissection of the cardia and the ca from DI-3/UAS-gfp flies of different
ages and observed directly under a binocular lamp fit with a green
fluorescent filter (Leica, MZ FLIII). The GFP is driven by DI-3 in the ca in
a temporal dynamic pattern. In two days old adult flies (left panel), the
GFP is well detectable in the ca (arrowhead), but not anymore in 5 days
old flies (right panel). However, in 5 days old flies, the GFP is detectable
in a thin layer of the cardia. g) Dissection of cardia and ca from (DI-11/
UAS-gfp) directly observed under a binocular lamp fit with a green
fluorescent filter (Leica, MZ FLIII). DI-11 also drives the expression of GFP
in the ca (arrowhead), and this expression is permanent in adult flies. h)
GFP (left) and HMGCR (middle) are detected respectively with primary
antibodies against GFP and HMGCR and revealed with secondary
antibodies respectively labeled with FITC (green) and Cy3 (red). When
merged, we can see that the GFP and HMGCR are colocalized (right
panel: yellow), confirming that the DI-11 drives the GFP in the same
cells of the ca that express the HMGCR. Scale bar=25 mm.
doi:10.1371/journal.pone.0000187.g003
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significantly different start/stop number, compared to control flies,
confirming that DI-3 is sufficient to rescue the sexual dimorphism.
Most interesting was the observation that the expression of DI-3
disappeared after approximately 4 days. After the first locomotor
activity quantification, flies were re-collected and maintained on
normal food medium during 3 additional days, after which loco-
motor activity was again recorded and the start/stop numbers
determined. Figure 4 shows that these five days old flies exhibited
a mutant phenotype: males and females start/stop number was
similar. This result concurs with the observed expression pattern of
the gfp transgene under the control of DI-3, suggesting that before
3 days, hmgcr transgene is expressed in both the ca and the rest of
the body (comprising the PI neurons), while after 4 days old, the
transgene, driven only by act-GAL4 promoter, is not expressed
anymore in the ca. This result suggests that HMGCR plays a role
in the sexual dimorphism, by acting specifically within the ca.
However, due to the reporter gene expression pattern of DI-3 in
some other neurons and tissues, we can not exclude if PI and/or
larval fat body cells could also be implicated in the control of start/
stop number.
Directed expression of RNAi-HMGCR in the corpus
allatum abolishes sexual dimorphism and mimics
the hmgcr mutant phenotype
To determine more precisely the tissues where HMGCR is
required to promote the sexual dimorphism in locomotor activity,
we used an interferential RNA (RNAi) against the hmgcr gene. For
each experiment, DI-3 line in combination with one of the two
p[UAS-RNAi-HMGCR] lines (10367R1 and 10367R3, inserted
on the chromosome III and II respectively; a generous gift from R.
Ueda, NIG, Japan) were used to avoid non specific P element
insertion side effect. We found that flies carrying the UAS-RNAi-
HMGCR driven by either the da-GAL4 ubiquitous driver or by
the act-GAL4 driver, yields lethality to the second instars larva.
Although we can not exclude a non specific toxic effect, this
phenotype is comparable to lethality induced by hmgcr mutations.
Compared to controls: DI-3/CS and/or UAS-RNAi-HMGCR/
CS, no HMGCR was detected in the ca in 2 days old flies when
the UAS-RNAi-HMGCR was driven by DI-3 (Figures 5a and 5b).
It is worth reiterating, that in 2 days old flies, DI-3 does not drive
expression of UAS-gfp in the cardia (see Figure 3f) and we can
presume that the expression pattern is the same for UAS-RNAi-
HMGCR. Indeed, the cardia (Figure 5g) is sufficiently immuno-
reactive independently of the presence of the UAS-RNAi-
HMGCR transgene. This result confirms that HMGCR is not
detectable in tissues simultaneously expressing the GAL4 driver
and the UAS-RNAi-HMGCR and thus, validates the specificity of
action of the latter. In accordance with previous results, two days
old flies without HMGCR expression in the ca (DI-3/UAS-RNAi-
HMGCR) did not show the sexual dimorphism in locomotor
activity (Figure 5b). Furthermore, UAS-RNAi-HMGCR/CS
control flies expressing HMGCR in the ca, harbor a wild type
phenotype, as the sexual dimorphism is present (Figure 5a). As for
the former experiment, all the 2 days old recorded flies were kept
for further re-evaluation, and then, placed in a new food medium
for 3 days before their locomotor activity was once again quanti-
fied. As expected, all five days old flies (controls UAS-RNAi-
HMGCR/CS or DI-3/UAS-RNAi-HMGCR) present a sexual
dimorphism comparable to a wild-type phenotype (Figures 5c and
5d). Indeed, as previously observed with the UAS-gfp, DI-3 does
not drive UAS-RNAi-HMGCR in flies older than 4 days. This
result together with the data supporting the presence of HMGCR
protein in the ca (Figure 5d), suggests that the action of the RNAi is
at least partly reversible. However, we can still not exclude
a possible action of HMGCR in PI and/or residual larval fat body
Figure 5. Directed expression of p[UAS-RNAi-HMGCR] specifically in
the corpus allatum mimics the hmgcr mutation, by disrupting the
sexual dimorphism. For all panels (a–g): immunostaining using
a primary antibody raised against the human form of the HMGCR,
revealed with a secondary antibody labeled with Cy3 (red). a–d)
Targeting UAS-RNAi-HMGCR specifically in the ca yields to the lack of
the HMGCR protein, and leads to the disruption of the sexual
dimorphism. This effect is completely reversible. In 2 days old DI-3/
UAS-RNAi-HMGCR flies (b), HMGCR protein is not detectable and the
number of start/stop is identical between males and females compared
to controls (a) (2 days old UAS-RNAi-HMGCR/CS flies). Interestingly, in
5 days old flies, both DI-3/UAS-RNAi-HMGCR (d) and UAS-RNAi-HMGCR/
CS (c) the HMGCR is detectable and the start/stop number is sexually
dimorphic. This is in agreement with the temporal expression pattern
driven by the DI-3. Additionally, this result strongly suggests the
reversibility of the RNAi effect. N.B: results from b) and d) come from the
same flies, recorded at 2 and 5 days old respectively. e, f) Expressing the
UAS-RNAi-HMGCR in the ca using the DI-11 line (DI-11/UAS-RNAi-
HMGCR) also leads to the lack of the HMGCR product (f) and disrupts
the sexual dimorphism compared to controls flies (e). g) The HMGCR is
expressed both in the cardia and the ca (left panel) in control flies
(2 days old UAS-RNAi-HMGCR/CS flies), whereas in 2 days old (DI-3/
UAS-RNAi-HMGCR) flies, the HMGCR is detected only in the cardia (right
panel). This last staining serves as a positive control, to demonstrate
that the DI-3 drives the UAS-RNAi-HMGCR only in the ca. h) Expressing
the UAS-RNAi-HMGCR in the ca under the control of DI-11 leads to
a strong lethality when flies are reared at 24uC. Moreover, the only few
females that survived are dwarf (left: dwarf female DI-11/UAS-RNAi-
HMGCR, middle: female control UAS-RNAi-HMGCR/CS] and right: female
CS). Scale bar=25 mm.
doi:10.1371/journal.pone.0000187.g005
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RNAi-HMGCR in the ca. When reared at 24uC, DI-11/UAS-
RNAi-HMGCR larvae are smaller than control (half size)
(Figure 5h) and a strong lethality is observed in third instars
larvae, as very few adults survive: less than 1% and females only.
Fortunately, when reared at 19uC, 10% and 1% of expected adult
females and males, respectively, survive and have normal weight
and size. As we can expect for these flies, a lack of sexual dimor-
phism is observed in correlation with the absence of HMGCR
expression in the ca (Figure 5f) compared to the relevant controls
(Figure 5e). These results are in accordance with those obtained
using the DI-3 line. To exclude possible contributions from other
tissues in the sexual dimorphism, and more particularly the
involvement of the HMGCR expressed in PI and/or residual
larval fat body cells, we used two other GAL4 driver lines,
p[GAL4]C316 (C316) and elav-GAL4 to drive UAS-RNAi-
HMGCR. C316 induces UAS-gfp expression in the larval fat
body, in the cardia and in DPM neurons (data not shown) [58],
while elav-GAL4 is a pan-neural GAL4-driver [52]. Flies from
either elav-GAL4/UAS-RNAi-HMGCR or C316/UAS-RNAi-
HMGCR display a wild type start/stop number compared to
controls (data not shown). Altogether, these results strongly suggest
that HMGCR expression in the ca is necessary for flies to present
the sexually dimorphic locomotor activity.
Directed expression of RNAi-InR in the corpus
allatum abolishes the sexual dimorphism and
mimics the hmgcr mutation
In a previous study [21], we reported that the insulin signaling
pathway is implicated in the start/stop number control, and in
parallel, that the insulin receptor (InR) is expressed in the ca. Using
the same strategy, we used the DI-3 line to drive a RNAi against
the InR gene (p[UAS-RNAi-InR]) in the ca. As before, the DI-3
line and two UAS-RNAi-InR lines (18402R1 and 18402R2,
inserted on the chromosome II and III respectively, also a generous
gift from R. Ueda, NIG, Japan) have been used to avoid non
specific P element insertion side effect. Again here, flies carrying
a UAS-RNAi-InR driven either by act-GAL4 or by da-GAL4 lines
are lethal in the second instars larva. However, using the DI-3
driver line, we obtained flies from 2 days old (DI-3/UAS-RNAi-
InR), which do not have InR expression in ca (Figure 6b), while the
start/stop number is not different between males and females (no
sexual dimorphism) compared to controls (Figure 6a). Both sexual
dimorphism and InR expression are completely restored in 5 day
old DI-3/UAS-RNAi-InR flies, which are comparable to control
flies: DI-3/CS and UAS-RNAi-InR/CS (Figure 6c) (as previously,
the same flies are recorded at 2 and 5 days old). Similarly to the
UAS-RNAi-HMGCR/CS flies, UAS-RNAi-InR/CS flies are
normal, suggesting a very putative restricted non specific mis-
cellaneous expression of RNAi. Another similarity to the RNAi-
HMGCR, is that the RNAi-InR effects are at least partly reversi-
ble. We previously showed that using the DI-11 in combination
with the UAS-RNAi-HMGCR leads to lethality at 24uC. Also
here, using UAS-RNAi-InR driven by the DI-11 yields lethality at
24uC. However, when reared at 19uC, we obtained few adult
females (less than 1%) that are dwarf and die after about 5 days
(Figure 6d). To confirm the specific role of HMGCR within the ca
versus the one expressed in the PI or in the residual larval fat body
cells, we used again the two GAL4 driver lines, C316 and elav-
GAL4 to drive the UAS-RNAi-InR. In both cases, neither InR
expression and/or the sexual dimorphism were affected (data not
shown). In conclusion, InR expression in the ca seems to be
necessary for establishing the sexual dimorphism.
Figure 6. Directed expression of p[UAS-RNAi-InR] specifically in the
corpus allatum, mimics the hmgcr mutation. For all panels (a–c):
immunostaining using a primary antibody raised against the human
form of the InR, revealed by a secondary antibody labeled with FITC
(green). a–c) Targeting the UAS-RNAi-InR specifically in the ca blocks
the InR expression and disrupts the sexual dimorphism. This effect is
completely reversible. In 2 days old DI-3/UAS-RNAi-InR flies (b), InR is
not detectable and the number of start/stop is identical between males
and females compared to controls flies (a) (2 days old UAS-RNAi-InR/
CS). Interestingly, in 5 days old DI-3/UAS-RNAi-InR flies (c) the InR is
detectable and the start/stop number is sexually dimorphic. This result
corroborates the temporal expression pattern driven by the DI-3.
Additionally, this strongly suggests, like for the RNAi-HMGCR, the
reversibility of the RNAi-InR effect. N.B.: again here, results from b) and
d) come from the same flies, recorded at 2 and 5 days old, respectively.
d) Expressing the UAS-RNAi-InR in the ca under the control of DI-11
leads to a strong lethality when flies are reared at 24uC and 19uC.
However, at 19uC, few females survive, but they are dwarf (left: dwarf
female DI-11/UAS-RNAi-InR, right: female control (UAS-RNAi-InR/CS).
Scale bar=25 mm.
doi:10.1371/journal.pone.0000187.g006
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dimorphism via hmgcr
We have shown that InR and hmgcr are both expressed in the ca.
When a RNAi-HMGCR or a RNAi-InR is driven specifically in
the ca by DI-3 or DI-11 drivers, this leads to a disruption of the
sexual dimorphism in locomotor activity. To demonstrate that the
InR and HMGCR are expressed in the same ca’s cells, we
performed a double immunostaining against HMGCR and InR.
Figure 7a shows that those two proteins are colocalized. Using the
DI-3 and/or the DI-11 as drivers, we first showed that expressing
the RNAi-HMGCR in the ca does not affect InR expression
(Figure 7a). Conversely, expression of an RNAi-InR completely
suppresses hmgcr expression. Similarly to previous reports in
mammalian cells [42], these results suggest a putative transcrip-
tional control exerted by InR on hmgcr. Furthermore, since DI-3
drives expression of UAS-RNAi only up to 3 days, then expression
of both InR and/or HMGCR, which correlates to the sexual
dimorphism, is restored at 5 days. This confirms that the RNAi
effects are reversible (Figure 7a). However, no direct evidence that
the disruption of the sexual dimorphism could be attributed to the
lack of HMGCR rather than to the InR. Indeed, both HMGCR
and InR could be needed for the sexual dimorphism, but in
independent pathways. In order to determine more precisely a
functional link between these two proteins in relation to their
respective roles in the control of sexual dimorphism, we expressed
both hmgcr (using UAS-clb) and UAS-RNAi-InR under the control
of the DI-3 driver. We found that InR was still undetectable whereas
HMGCR waswellpresentinthe cain3 daysold flies (Figure 7a)and
the sexual dimorphism of these flies was determined to be wild type
(Figure 7b). Taken together, these results strongly suggest, as in
mammals [42], a transcriptional control of HMGCR by the insulin
signaling pathway in the ca. In addition, InR seems to control the
sexual dimorphism through the HMGCR enzyme.
DISCUSSION
A specific physiological role for the HMGCR
We have shown, in Drosophila, by immuno-histological staining,
that HMGCR is expressed in a variety of tissues, including the
digestive tract, the brain and the ca. Moreover, this expression
pattern appears to be temporally dynamic. Here, the genesis of
two transgenic p[hmgcr-GAL4] driver lines (DI-3 and DI-11)
corresponding to the promoter regions of the two transcripts
(mRNAA and mRNAB) respectively, have allowed different
reporter genes to be targeted specifically in the ca, allowing more
precise studies on its specific physiological role. Using the UAS-gfp
as reporter gene, we showed that the putative promoter sequence
of mRNA-a (DI-3) drives GFP expression in some cells of the PI
within the brain. Furthermore, in young flies less than 3 days old,
GFP expression is found in the digestive tract, in the residual larval
fat body and in the ca. In contrast, DI-11 has a more restricted
spatio-temporal expression pattern. Indeed, in DI-11, only
oesophagus and ca are stained. Nevertheless, if we superimpose
the expression pattern of DI-3 and DI-11, the observed pattern is
included, but not fully equivalent to the endogenous HMGCR’s
one. Thus, this suggests that the two selected 59 genomic DNA
regions do not include the full endogenous promoter region.
To refine our study, we used two new GAL4 drivers (DI-3 and
DI-11) to target an RNAi-HMGCR directly into the ca.N o
HMGCR expression was detected by immuno-histochemistry in
the ca of 5 days old DI-11/RNAi-HMGCR flies and this effect was
correlated with an equal start/stop number between males and
females. Results obtained with DI-3 were more complex, but
informative, as its expression pattern is temporally dynamic.
Indeed, DI-3 drives RNAi-HMGCR in the ca in flies younger than
3 days old, and in this case, HMGCR was not detectable in ca.I n
parallel, the start/stop number was found to be the same for males
and females. However, as expected, 5 days old DI-3/RNAi-
HMGCR flies behave strictly as controls, since HMGCR is, de
novo, expressed in the ca. Altogether, these results confirm that
HMGCR expression in the ca is necessary for a sexually dimorphic
start/stop number. In addition, RNAi effects are reversible: the
same DI-3/RNAi-HMGCR flies were recorded at 2 and 5 days old.
This reversibility indicates that the specific effects observed in adults
after RNAi induction on locomotion are physiological rather than
developmental consequences resulting from the lack of HMGCR.
Insulin pathway controls the sexual dimorphism in
the corpus allatum
Previous studies have shown that mutations in Insulin Receptor
(InR) decrease JH level [15,59], a hormone synthesized in the ca
and implying the HMGCR enzyme. Moreover, we have shown,
using a genetic approach, that InR is implicated in the control of
the sexual dimorphism in locomotor activity [21]. Here, driving an
RNAi-InR specifically in the ca abolishes the sexual dimorphism.
Figure 7. Insulin signaling pathway controls the sexual dimorphism
via HMGCR. a) Immunostaining using primary antibodies against the
InR and/or HMGCR, revealed by secondary antibodies labeled with FITC
(green) or Cy3 (red) respectively. HMGCR and InR are colocalized in the
same cells of the ca. Blocking the expression of the HMGCR does not
influence the expression of the InR, but abolishes the sexual
dimorphism. However, blocking the expression of the InR blocks the
expression of the HMGCR and consequently abolishes the sexual
dimorphism. This suggests that the InR controls the expression of the
HMGCR within the ca. To test this hypothesis, we directed the
expression of the UAS-clb concomitantly with the UAS-RNAi-InR (DI-3/
UAS-RNAi-InR; UAS-clb). In this case, although InR is not detectable,
HMGCR is present in the ca and the start/stop number is sexually
dimorphic between males and females (b). Scale bar=25 mm.
doi:10.1371/journal.pone.0000187.g007
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in this tissue to promote its effect on the sexual dimorphism.
Furthermore, the reversibility of the effect observed with DI-3/
UAS-RNAi-InR in 5 days old flies compared to 2 days old flies,
tends to exclude an IGF-like effect of InR pathway on ca cells
during development that could alter the functional capacity of ca.
This is the first time that a ‘‘tissue specific action’’ of insulin, not
directly related to development or carbohydrate metabolism, is
reported in Drosophila.
InR mutations or IPCs ablation lead to a diabetes like
phenotype: trehalosemia is increased in both larvae and adults
[8,13–15,21]. Interestingly, neither hmgcr mutant nor RNAi-
HMGCR or RNAi-InR expressed in the ca increase haemolymph
sugar level (data not shown). This reveals a new and very specific
functional role for the insulin signaling pathway in the ca. More-
over, when driven by DI-3, RNAi-InR blocks hmgcr expression and
this action is completely reversed in flies older than five days.
Although we can not exclude an IGF like action of insulin in ca
during development, inr mutations did not affect ca size [59] and
the reversibility of RNAi effects in adult flies strongly suggest that
the implication of the InR and HMGCR in such physiological
processes, is dynamically active.
Insulin pathway controls HMGCR expression in the
corpus allatum
A number of clues suggests an interaction between the insulin
pathway and JH [15,21]. In mammalian hepatocytes, HMGCR
has been shown to be partially under control of insulin [40]. In
Drosophila, the HMGCR is the key step in JH biosynthesis, which is
known to occur in the ca. We report here that specifically silencing
the inr gene in ca, under the control of DI-3 or DI-11, leads to
decreased HMGCR, which abolishes sexual dimorphism. More-
over, this phenotype can be rescued by directed expression of the
hmgcr gene within the ca. Similarly to results found in mammalian
hepatocytes, this strongly suggests that the insulin signaling path-
way might control the expression of the hmgcr gene. In hepatocytes,
insulin is reported to act on hmgcr transcription through a helix-
loop-helix transcription factor called SREBP-1c (Sterol Response
Element Binding Protein) [40]. Although three SREBP isoforms
have been identified, it appears that only the SREBP-1c form
responds to insulin. The two others are more sensitive to
cholesterol, which inhibits hmgcr gene expression through a negative
feed back loop. In Drosophila, only one SREBP homolog has been
identified: hlh-106 (dSREBP) [49,50]. In a recent study, dSREBP
was found to be expressed in ca cells [49]. We used DI-3 and
DI-11 lines to drive a dominant negative form of this gene:
p[UAS-dsrebp
DN] (UAS-dsrebp
DN) in the ca and observe a lack of
sexual dimorphism (Figure S1). Furthermore, when using DI-3 to
drive the UAS-dsrebp
DN cDNA gene, the sexual dimorphism was
retrieved in flies older than 5 days. These results resemble those
obtained after the disturbance of InR or HMGCR expression in
the ca. SREBP may therefore be a molecular link between InR and
HMGCR in ca (Figure 8).
Body size depends of the hmgcr
In Drosophila, the insulin signaling pathway regulates growth in
accordance with the nutritional availability during development
[7,16,26,27]. Disruption of various components of this pathway
leads to delayed and small (dwarf) flies [6,8,12,16]. However, very
little is known about the precise tissue specificity of the insulin
pathway’s action requirement. In fact, in contrast to mammals
which display a wide variety of growth factors [60], the pre-
dominant role of insulin pathway in development points to an
action occurring in all cells of the organism [16,17,26]. However,
in some cases, some organs seem to be more or less affected
compared to others [61], while a recent study showed dwarf and
delayed larvae in flies lacking SREBP in some specific tissues [49].
In certain temperature conditions, we observed delayed and small
(dwarf) flies by disrupting InR and/or HMGCR expression or
using dominant negative forms of SREBP specifically targeted in
the ca. Taken together, these results strongly suggest a crucial role
of these components (InR-HMGCR-SREBP), specifically in the ca
for controlling body size. Although these components are linked
to the insulin pathway, our results suggest a new mechanism,
probably involving neuroendocrine control by JH, which would be
independent of the IGF-like role of insulin occurring in all cells, to
determine the body size.
The sexual dimorphism in locomotor activity
We showed that HMGCR and InR (as well as the first results
obtained with SREBP), specifically within the ca, are implicated in
the control of the sexual dimorphism. Moreover, we have not
detected any sexual difference neither in InR, nor in HMGCR
expression pattern or in the efficiency of inr and/or hmgcr RNAi
silencing, suggesting that the sexual dimorphism in locomotor
activity does not rely in the expression pattern of these genes.
Previous studies have shown the implication of some PI neurons in
the control of the sexual dimorphism, as those neurons have been
feminized by the directed expression, in males, of the female
version of the sexual determination factor transformer (tra), leading
to name those cells ‘‘feminizing cells’’ (FCs) [28,29]. Moreover, we
have shown that these cells act on the sexual dimorphism through
a neuroendocrine factor, by regulating the synthesis or JH release,
probably by acting on the ca’s cells. Here, in this study, we
observed that the directed expression of tra in the IPCs does
Figure 8. Model of the insulin pathway regulating the expression of
the HMGCR in the corpus allatum. We hypothesize that the two
different populations of cells, the Insulin Producing Cells (IPCs) and the
feminising cells (FCs), located in the pars intercerebralis control, by two
distinct ways, the JH synthesis/release by the corpus allatum. The
informative way (in yellow), which could be feminised, might control
the level or the timing of the JH release, while the permissive way (in
green) might control or allow the presence of the molecular machinery,
as the transcription of the HMGCR, to promote the JH synthesis. In
magnification: in the corpus allatum, insulin binds to its receptor (InR),
which activates SREBP. In turn, SREBP regulates the transcription of
hmgcr gene.
doi:10.1371/journal.pone.0000187.g008
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likely that two independent mechanisms could control the sexual
dimorphism. The first, composed by the FCs, might act on the
cells of the ca and consequently on the JH. This could be qualified
as the ‘‘informative’’ way. The second way composed by the IPCs,
might act on the cells of the ca that express the InR and HMGCR
components (Figure 8). This could be qualified as the ‘‘permissive’’
way that allow the HMGCR activity and consequently, the
synthesis of the JH. In brief, the informative way may control the
level of synthesis and/or the timing of JH release, while the
permissive way could allow the synthesis of JH. This could suggest
that the informative, but not the permissive way is tra-sensitive.
Additionally, this could also suggest that the disruption of the
permissive way abolishes the sexual dimorphism. The precise
interaction between these two putative ways still remains to be
thoroughly characterized.
In parallel, other studies have demonstrated that disrupting the
insulin pathway increases longevity [13,15,62], while in some
cases, it also disrupts the sexual dimorphism [21]. It will be
relevant to determine if the inactivation of the expression of either
the inr and hmgcr genes, specifically in the ca, using the RNAi
technology (DI-11/RNAi-InR and DI-11/RNAi-HMGCR) could
also increase longevity. In summary, we investigated the role of the
HMGCR in adult flies in these studies and find a functionally
conserved link between InR and HMGCR. This could lead to the
establishment of a new model to study the molecular and
physiological roles of the reductase in a relatively simple organism.
MATERIALS AND METHODS
Flies stock
All Drosophila melanogaster lines were maintained at 24uCo n
standard food medium. Wild-type Canton Special (CS) flies
were used. P[GAL4]C316 was kindly provided by S. Waddell




04684), p[UAS-gfp], p[elav-GAL4], p[daughterless-
GAL] and p[actin-GAL4] lines were obtained from the Bloo-
mington Drosophila Stock Centre. p[UAS-RNAi-InR] (18402-R1
and 18402-R2) and p[UAS-RNAi-HMGCR] (10367-R1 and
10367-R3) were kindly provided by R. Ueda (NIG, Japan).
Quantification of locomotor activity (start/stop
number)
A previously described paradigm was used [28,30]. Two, four, or
five days old flies were allowed to walk in a small square arena
(464 cm, 3.5 mm high) for five hours. A camera placed above the
arena recorded fly movements (Ethovision, Noldus, Netherland).
The number of activity and inactivity phases (also equivalent to the
starts/stops number) was quantified by the computer software.
Since in some cases, the level of locomotor activity differs among
groups with different genotypes, the number of start/stop was
normalized by designating the females of each group as the
reference (expressed as 100%) and comparing males in the same
group to the females. Flies and their respective controls were
always recorded at the same time. All experiments were performed
at 24uC and 60% humidity. Statistical comparisons were made
with ANOVA tests, using Statistica software (StatSoft, Inc.).
Genesis of the p[hmgcr-GAL4] construct and
Drosophila transgenic flies lines
To generate the p[hmgcr-GAL4] lines, we amplified by PCR, two
DNA fragments from wild-type CS, using a long range Taq DNA
polymerase (Invitrogen Long Range) according with the fabricant
protocol. The first fragment corresponds to the putative promoter
region controlling the transcription of the RNAA. For this
fragment (3857 pb length: 23569 bp to +288 bp from the start
site of the hmgcr gene), we used two primers flanked by a SfiI (SFI-
RB4) and EcoRI (Eco-RB5) restriction site to allow the insertion in
the pChsGAL4 plasmid. (SFI-RB4: ACGGCCTATGCGGCC-
CAGACGGTGAGTACAACGTA; Eco-RB5: ACGAATTCGT-
CTAGAGCGACTGCCAATT). The second fragment corre-
sponds to the putative promoter region controlling the transcrip-
tion of the RNAB. In order to amplify this second fragment
(10792 pb length: +2733 bp to +13525 bp from the start site of the
hmgcr gene), we used two primers also flanked by a SfiI (SFI-RB1)
and EcoRI (Eco-RB2). (SFI-RB1: ACGGCCTATGCGGCCC-
CAGCTCCAACATGATGCTA; Eco-RB2: ACGAATTCCCT-
TCGGTTTCTACGCACTT) restriction site. After digestion (by
SfiI and EcoRI) and purification, each fragment was inserted into
the pChsGAL4 plasmid. After transformation of JM109 bacteria,
we amplified, extracted, and purified the plasmids using a Mid-
iprep Kit (Quiagen). We then injected each construct/plasmid
with a helper plasmid in embryos (w-) Canton-S and selected
transgenic flies. Two independent transgenic lines carrying the
putative RNAA promoter were obtained and named DI-3-2 and
DI-3-3. Both independent insertions, homozygous viable, are on
the second chromosome and present the same expression pattern.
Thus, although all experiments have been performed with both
lines, since both lines give similar results, the results reported here
are from the line DI-3-3 (stated DI-3 in the text). One transgenic
line carrying the putative RNAB promoter was obtained and
named DI-11. The insertion site is on the third chromosome, and
is homozygous lethal.
Immunohistochemical techniques
Adult Drosophila heads were fixed (Carnoy) for mass histology
(paraffin section) or in 4% paraformaldehyde (PFA) (for cryostat
section) as described in Belgacem and Martin (2006) [21]. Seven-
micrometer sections were blocked for one hour in normal horse
serum (PBT0,05: PBS+0.05% Triton X-100). A primary anti-
HMGCR antibody raised from the human form (1/20 in PBT0,05)
(rabbit polyclonal antibody) (a courtesy of P. Edwards [33]), was
added, and incubated overnight at 4uC. After three washes in
PBT0,05, a secondary antibody Cy3-labeled anti-rabbit (1/500 in
PBT0,05; Amersham) was applied for one hour, at room tempera-
ture. After three washes in PBT0,05 and one in PBS, slices were
mounted in DABKO and observed by fluorescence microscopy.
Cardia and corpus cardiacum/corpus allatum were dissected in 4%
PFA at 4uC, incubated 30 min and washed in PBS (4uC) and twice
in PBT0,05. For double immunostaining (HMGCR and InR),
a primary anti-HMGCR antibody (1/20 in PBT0,05) (rabbit
polyclonal antibody) and a primary anti-InR antibody (1/20 in
PBT0,05) (a mouse monoclonal antibody against the human InR a-
subunit; Chemicon) were added, and incubated overnight at 4uC.
For double immunostaining (HMGCR and GFP), the primary
anti-HMGCR antibody (1/20 in PBT0,05) and a primary anti-GFP
mouse antibody (1/1000 in PBT0,05; Roche) were added, and
incubated overnight at 4uC. After three washes in PBS, the first
antibodies were recognized by Cy3-labeled anti-rabbit secondary
antibody (1/500 in PBT0,05; Amersham) for anti-HMGCR, and
FITC-conjugated anti-mouse (1/500 in PBT0,05; Sigma) second-
ary antibodies for anti-GFP or anti-InR. After three washes in
PBT0,05 and one in PBS, slices were mounted in DABKO and
observed by fluorescence microscopy.
For the double immunostaining (AKH and GFP), cardia and
corpus cardiacum/corpus allatum, have been prepared as described
above, except for antibodies. Primary antibodies, anti-HMGCR
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in PBT0,05) [56] were added and, after washes (in PBT0,05), anti-
HMGCR (Rabbit ) were recognized by FITC-conjugated anti-
mouse (1/500 in PBT0,05; Sigma) secondary antibody.
SUPPORTING INFORMATION
Figure S1 Targeted expression of a dominant negative form of
SREBP in the corpus allatum abolishes the sexual dimorphism.
Expressing p[UAS-srebp
DN] in the ca under the control of DI-11
abolishes the sexual dimorphism (b) comparing to appropriated
controls p[UAS-srebp
DN]/CS (a).
Found at: doi:10.1371/journal.pone.0000187.s001 (0.06 MB TIF)
ACKNOWLEDGMENTS
We are indebted to R. Ueda (NIG, Japan) for providing RNAi lines
(18402R1, 18402R2, 10367R2 and 10367R3), S. Waddell for C316 line,
R. Lehmann for UAS-clb line, P.A. Edwards for anti-HMGCR antibodies,
and G. Isabel for anti-AKH antibodies. We also thank K. Rogers for helps
in English writing and J. Montagne for the critical reading of the
manuscript, as well as M.C. Ibrahim, A. Ikmi and B. Fontaine for helpful
advices and discussions.
Author Contributions
Conceived and designed the experiments: JM YB. Performed the
experiments: YB. Analyzed the data: JM YB. Contributed reagents/
materials/analysis tools: JM. Wrote the paper: JM YB.
REFERENCES
1. Takahashi Y, Tobe K, Kadowaki H, Katsumata D, Fukushima Y, et al. (1997)
Roles of insulin receptor substrate-1 and Shc on insulin-like growth factor I
receptor signaling in early passages of cultured human fibroblasts. Endocrinol-
ogy 138: 741–750.
2. Butler AA, Le Roith D (2001) Control of growth by the somatropic axis: growth
hormone and the insulin-like growth factors have related and independent roles.
Annu Rev Physiol 63: 141–164.
3. Saltiel AR, Kahn CR (2001) Insulin signalling and the regulation of glucose and
lipid metabolism. Nature 414: 799–806.
4. Foufelle F, Ferre P (2001) [Regulation of carbohydrate metabolism by insulin:
role of transcription factor SREBP-1c in the hepatic transcriptional effects of the
hormone]. J Soc Biol 195: 243–248.
5. Penhos JC, Wu CH, Lemberg A, Daunas J, Brodoff B, et al. (1968) The effect of
insulin on the metabolism of lipids and on urea formation by the perfused rat
liver. Metabolism 17: 246–259.
6. Brogiolo W, Stocker H, Ikeya T, Rintelen F, Fernandez R, et al. (2001) An
evolutionarily conserved function of the Drosophila insulin receptor and insulin-
like peptides in growth control. Curr Biol 11: 213–221.
7. Ikeya T, Galic M, Belawat P, Nairz K, Hafen E (2002) Nutrient-dependent
expression of insulin-like peptides from neuroendocrine cells in the CNS
contributes to growth regulation in Drosophila. Curr Biol 12: 1293–1300.
8. Rulifson EJ, Kim SK, Nusse R (2002) Ablation of insulin-producing neurons in
flies: growth and diabetic phenotypes. Science 296: 1118–1120.
9. Cao C, Brown MR (2001) Localization of an insulin-like peptide in brains of two
flies. Cell Tissue Res 304: 317–321.
10. Fernandez R, Tabarini D, Azpiazu N, Frasch M, Schlessinger J (1995) The
Drosophila insulin receptor homolog: a gene essential for embryonic de-
velopment encodes two receptor isoforms with different signaling potential.
EMBO J 14: 3373–3384.
11. Song J, Wu L, Chen Z, Kohanski RA, Pick L (2003) Axons guided by insulin
receptor in Drosophila visual system. Science 300: 502–505.
12. Chen C, Jack J, Garofalo RS (1996) The Drosophila insulin receptor is required
for normal growth. Endocrinology 137: 846–856.
13. Broughton SJ, Piper MD, Ikeya T, Bass TM, Jacobson J, et al. (2005) Longer
lifespan, altered metabolism, and stress resistance in Drosophila from ablation of
cells making insulin-like ligands. Proc Natl Acad Sci USA 102: 3105–3110.
14. Britton JS, Lockwood WK, Li L, Cohen SM, Edgar BA (2002) Drosophila’s
insulin/PI3-kinase pathway coordinates cellular metabolism with nutritional
conditions. Dev Cell 2: 239–249.
15. Tatar M, Kopelman A, Epstein D, Tu MP, Yin CM, et al. (2001) A mutant
Drosophila insulin receptor homolog that extends life-span and impairs
neuroendocrine function. Science 292: 107–110.
16. Shingleton AW, Das J, Vinicius L, Stern DL (2005) The temporal requirements
for insulin signaling during development in Drosophila. PLoS Biol 3: e289.
17. Montagne J, Stewart MJ, Stocker H, Hafen E, Kozma SC, et al. (1999)
Drosophila S6 kinase: a regulator of cell size. Science 285: 2126–2129.
18. Stocker H, Radimerski T, Schindelholz B, Wittwer F, Belawat P, et al. (2003)
Rheb is an essential regulator of S6K in controlling cell growth in Drosophila.
Nat Cell Biol 5: 559–565.
19. Wu Q, Zhang Y, Xu J, Shen P (2005) Regulation of hunger-driven behaviors by
neural ribosomal S6 kinase in Drosophila. Proc Natl Acad Sci USA 102:
13289–13294.
20. Wu Q, Zhao Z, Shen P (2005) Regulation of aversion to noxious food by
Drosophila neuropeptide Y- and insulin-like systems. Nat Neurosci 8:
1350–1355.
21. Belgacem YH, Martin JR (2006) Disruption of insulin pathways alters trehalose
level and abolishes sexual dimorphism in locomotor activity in Drosophila.
J Neurobiol 66: 19–32.
22. Bohni R, Riesgo-Escovar J, Oldham S, Brogiolo W, Stocker H, et al. (1999)
Autonomous control of cell and organ size by CHICO, a Drosophila homolog of
vertebrate IRS1-4. Cell 97: 865–875.
23. Clancy DJ, Gems D, Harshman LG, Oldham S, Stocker H, et al. (2001)
Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate
protein. Science 292: 104–106.
24. Araki E, Kahn CR, Shichiri M (1994) [Characterization of the IRS-1 (insulin
receptor substrate-1) gene and its promoter]. Nippon Rinsho 52: 2659–2664.
25. Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, et al. (1998) Disruption
of IRS-2 causes type 2 diabetes in mice. Nature 391: 900–904.
26. Colombani J, Raisin S, Pantalacci S, Radimerski T, Montagne J, et al. (2003) A
nutrient sensor mechanism controls Drosophila growth. Cell 114: 739–749.
27. Colombani J, Bianchini L, Layalle S, Pondeville E, Dauphin-Villemant C, et al.
(2005) Antagonistic actions of ecdysone and insulins determine final size in
Drosophila. Science 310: 667–670.
28. Belgacem YH, Martin JR (2002) Neuroendocrine control of a sexually
dimorphic behavior by a few neurons of the pars intercerebralis in Drosophila.
Proc Natl Acad Sci USA 99: 15154–15158.
29. Gatti S, Ferveur JF, Martin JR (2000) Genetic identification of neurons
controlling a sexually dimorphic behaviour. Curr Biol 10: 667–670.
30. Martin JR (2004) A portrait of locomotor behaviour in Drosophila determined
by a video-tracking paradigm. Behav Processes 67: 207–219.
31. Belles X, Martin D, Piulachs MD (2005) The mevalonate pathway and the
synthesis of juvenile hormone in insects. Annu Rev Entomol 50: 181–199.
32. Singer II, Kawka DW, Kazazis DM, Alberts AW, Chen JS, et al. (1984)
Hydroxymethylglutaryl-coenzyme A reductase-containing hepatocytes are
distributed periportally in normal and mevinolin-treated rat livers. Proc Natl
Acad Sci U S A 81: 5556–5560.
33. Li AC, Tanaka RD, Callaway K, Fogelman AM, Edwards PA (1988)
Localization of 3-hydroxy-3-methylglutaryl CoA reductase and 3-hydroxy-3-
methylglutaryl CoA synthase in the rat liver and intestine is affected by
cholestyramine and mevinolin. J Lipid Res 29: 781–796.
34. Dietschy JM, Turley SD, Spady DK (1993) Role of liver in the maintenance of
cholesterol and low density lipoprotein homeostasis in different animal species,
including humans. J Lipid Res 34: 1637–1659.
35. Irons M, Elias ER, Tint GS, Salen G, Frieden R, et al. (1994) Abnormal
cholesterol metabolism in the Smith-Lemli-Opitz syndrome: report of clinical
and biochemical findings in four patients and treatment in one patient. Am J Med
Genet 50: 347–352.
36. Grundy SM (1986) Cholesterol and coronary heart disease. A new era. Jama
256: 2849–2858.
37. Brown MS, Goldstein JL (1986) A receptor-mediated pathway for cholesterol
homeostasis. Science 232: 34–47.
38. Azrolan NI, Coleman PS (1989) A discoordinate increase in the cellular amount
of 3-hydroxy-3-methylglutaryl-CoA reductase results in the loss of rate-limiting
control over cholesterogenesis in a tumour cell-free system. Biochem J 258:
421–425.
39. Duncan RE, El-Sohemy A, Archer MC (2005) Statins and cancer development.
Cancer Epidemiol Biomarkers Prev 14: 1897–1898.
40. Ness GC, Chambers CM (2000) Feedback and hormonal regulation of hepatic
3-hydroxy-3-methylglutaryl coenzyme A reductase: the concept of cholesterol
buffering capacity. Proc Soc Exp Biol Med 224: 8–19.
41. Lakshmanan MR, Nepokroeff CM, Ness GC, Dugan RE, Porter JW (1973)
Stimulation by insulin of rat liver -hydroxy–methylglutaryl coenzyme A
reductase and cholesterol-synthesizing activities. Biochem Biophys Res Commun
50: 704–710.
42. Osborne AR, Pollock VV, Lagor WR, Ness GC (2004) Identification of insulin-
responsive regions in the HMG-CoA reductase promoter. Biochem Biophys Res
Commun 318: 814–818.
43. Cagen LM, Deng X, Wilcox HG, Park EA, Raghow R, et al. (2005) Insulin
activates the rat sterol-regulatory-element-binding protein 1c (SREBP-1c)
promoter through the combinatorial actions of SREBP, LXR, Sp-1 and NF-Y
cis-acting elements. Biochem J 385: 207–216.
44. Clayton RB (1964) The Utilization of Sterols by Insects. J Lipid Res 15: 3–19.
45. Van Doren M, Broihier HT, Moore LA, Lehmann R (1998) HMG-CoA
reductase guides migrating primordial germ cells. Nature 396: 466–469.
Sexual Dimorphism & Body Size
PLoS ONE | www.plosone.org 10 January 2007 | Issue 1 | e18746. Thorpe JL, Doitsidou M, Ho SY, Raz E, Farber SA (2004) Germ cell migration
in zebrafish is dependent on HMGCoA reductase activity and prenylation. Dev
Cell 6: 295–302.
47. Deshpande G, Schedl P (2005) HMGCoA reductase potentiates hedgehog
signaling in Drosophila melanogaster. Dev Cell 9: 629–638.
48. Tschape JA, Hammerschmied C, Muhlig-Versen M, Athenstaedt K, Daum G,
et al. (2002) The neurodegeneration mutant lochrig interferes with cholesterol
homeostasis and Appl processing. EMBO J 21: 6367–6376.
49. Kunte AS, Matthews KA, Rawson RB (2006) Fatty acid auxotrophy in
Drosophila larvae lacking SREBP. Cell Metab 3: 439–448.
50. Theopold U, Ekengren S, Hultmark D (1996) HLH106, a Drosophila
transcription factor with similarity to the vertebrate sterol responsive element
binding protein. Proc Natl Acad Sci USA 93: 1195–1199.
51. Plosker GL, Wagstaff AJ (1996) Fluvastatin: a review of its pharmacology and
use in the management of hypercholesterolaemia. Drugs 51: 433–459.
52. Yao KM, Samson ML, Reeves R, White K (1993) Gene elav of Drosophila
melanogaster: a prototype for neuronal-specific RNA binding protein gene
family that is conserved in flies and humans. J Neurobiol 24: 723–739.
53. Dauwalder B, Tsujimoto S, Moss J, Mattox W (2002) The Drosophila takeout
gene is regulated by the somatic sex-determination pathway and affects male
courtship behavior. Genes Dev 16: 2879–2892.
54. Ito K, Suzuki K, Estes P, Ramaswami M, Yamamoto D, et al. (1998) The
organization of extrinsic neurons and their implications in the functional roles of
the mushroom bodies in Drosophila melanogaster Meigen. Learn Mem 5: 52–77.
55. Wodarz A, Hinz U, Engelbert M, Knust E (1995) Expression of crumbs confers
apical character on plasma membrane domains of ectodermal epithelia of
Drosophila. Cell 82: 67–76.
56. Isabel G, Martin JR, Chidami S, Veenstra JA, Rosay P (2005) AKH-producing
neuroendocrine cell ablation decreases trehalose and induces behavioral changes
in Drosophila. Am J Physiol Regul Integr Comp Physiol 288: R531–538.
57. Lee G, Park JH (2004) Hemolymph sugar homeostasis and starvation-induced
hyperactivity affected by genetic manipulations of the adipokinetic hormone-
encoding gene in Drosophila melanogaster. Genetics 167: 311–323.
58. Waddell S, Armstrong JD, Kitamoto T, Kaiser K, Quinn WG (2000) The
amnesiac gene product is expressed in two neurons in the Drosophila brain that
are critical for memory. Cell 103: 805–813.
59. Flatt T, Tu MP, Tatar M (2005) Hormonal pleiotropy and the juvenile
hormone regulation of Drosophila development and life history. Bioessays 27:
999–1010.
60. Adamson ED (1993) Activities of growth factors in preimplantation embryos.
J Cell Biochem 53: 280–287.
61. Tu MP, Yin CM, Tatar M (2005) Mutations in insulin signaling pathway alter
juvenile hormone synthesis in Drosophila melanogaster. Gen Comp Endocrinol
142: 347–356.
62. Tatar M, Bartke A, Antebi A (2003) The endocrine regulation of aging by
insulin-like signals. Science 299: 1346–1351.
63. Wang D, Sul HS (1997) Upstream stimulatory factor binding to the E-box at -65
is required for insulin regulation of the fatty acid synthase promoter. J Biol Chem
272: 26367–26374.
64. Vallett SM, Sanchez HB, Rosenfeld JM, Osborne TF (1996) A direct role for
sterol regulatory element binding protein in activation of 3-hydroxy-3-
methylglutaryl coenzyme A reductase gene. J Biol Chem 271: 12247–12253.
Sexual Dimorphism & Body Size
PLoS ONE | www.plosone.org 11 January 2007 | Issue 1 | e187